Published in Infect Immun on January 01, 1980
Human immune responses to oral micro-organisms. I. Association of localized juvenile periodontitis (LJP) with serum antibody responses to Actinobacillus actinomycetemcomitans. Clin Exp Immunol (1982) 1.93
Human immune responses to oral microorganisms: patterns of systemic antibody levels to Bacteroides species. Infect Immun (1986) 1.26
Specific genetic variants of Actinobacillus actinomycetemcomitans correlate with disease and health in a regional population of families with localized juvenile periodontitis. Infect Immun (1994) 1.25
Bacteriological study of periodontal lesions in two sisters with juvenile periodontitis and their mother. Infect Immun (1984) 1.23
Phagocytosis of virulent Porphyromonas gingivalis by human polymorphonuclear leukocytes requires specific immunoglobulin G. Infect Immun (1991) 1.18
Resistance of a Tn4351-generated polysaccharide mutant of Porphyromonas gingivalis to polymorphonuclear leukocyte killing. Infect Immun (1995) 1.07
Defective neutrophil and monocyte motility in patients with early onset periodontitis. Infect Immun (1985) 1.01
Association of an abnormality of neutrophil chemotaxis in human periodontal disease with a cell surface protein. Infect Immun (1987) 0.97
Altered diacylglycerol level and metabolism in neutrophils from patients with localized juvenile periodontitis. Infect Immun (1992) 0.97
Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease. Infect Immun (1986) 0.97
Defective polymorphonuclear leukocyte formyl peptide receptor(s) in juvenile periodontitis. J Clin Invest (1991) 0.93
Suppression of bactericidal activity of human polymorphonuclear leukocytes by Bacteroides gingivalis. Infect Immun (1990) 0.92
Campylobacter surface-layers (S-layers) and immune evasion. Ann Periodontol (2002) 0.90
Localized aggressive periodontitis is linked to human chromosome 1q25. Hum Genet (2003) 0.89
Periodontitis as a risk factor of atherosclerosis. J Immunol Res (2014) 0.88
Calcium-dependent protein kinase C activity of neutrophils in localized juvenile periodontitis. Infect Immun (1993) 0.88
The Bi-Directional Relationship between Periodontal Disease and Hyperlipidemia. Eur J Dent (2008) 0.87
Measuring neutrophil speed and directionality during chemotaxis, directly from a droplet of whole blood. Technology (Singap World Sci) (2013) 0.85
Assessment of serum antibody patterns and analysis of subgingival microflora of members of a family with a high prevalence of early-onset periodontitis. Infect Immun (1985) 0.83
Changes in complement and immunoglobulin G receptor expression on neutrophils associated with Porphyromonas gingivalis-induced inhibition of phagocytosis. Infect Immun (1993) 0.83
PDK1 regulates chemotaxis in human neutrophils. J Dent Res (2009) 0.81
Ceruloplasmin induces polymorphonuclear leukocyte priming in localized aggressive periodontitis. J Periodontol (2009) 0.81
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins. Stem Cells Transl Med (2015) 0.81
Phagocyte function in juvenile periodontitis. Infect Immun (1990) 0.80
Subclass and molecular form of immunoglobulin A antibodies to Actinobacillus actinomycetemcomitans in juvenile periodontitis. Infect Immun (1991) 0.79
Evidence for polymorphonuclear leukocyte collagenase and 92-kilodalton gelatinase in gingival crevicular fluid. Infect Immun (1991) 0.79
Study of neutrophils isolated from peripheral blood of patients suffering from aggressive periodontitis at the cellular level: Receptors and cytoskeletal reorganization. J Indian Soc Periodontol (2012) 0.79
Impaired neutrophil directional chemotactic accuracy in chronic periodontitis patients. J Clin Periodontol (2015) 0.79
CD38 expression in neutrophils from patients with localized aggressive periodontitis. J Periodontol (2005) 0.78
Characterization of GP110, a neutrophil surface protein. Infect Immun (1992) 0.76
"What is there in a name?": A literature review on chronic and aggressive periodontitis. J Indian Soc Periodontol (2011) 0.75
PERIODONTAL DISEASE IN PREGNANCY. I. PREVALENCE AND SEVERITY. Acta Odontol Scand (1963) 15.52
PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION. Acta Odontol Scand (1964) 15.31
Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med (1973) 14.88
EXPERIMENTAL GINGIVITIS IN MAN. J Periodontol (1965) 7.13
The predominant cultivable microflora of advanced periodontitis. Scand J Dent Res (1977) 4.62
Defective granulocyte chemotaxis in the Chediak-Higashi syndrome. J Clin Invest (1971) 3.58
Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest (1976) 3.21
Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med (1971) 2.98
The predominant cultivable organisms in juvenile periodontitis. Scand J Dent Res (1976) 2.74
Lazy-leucocyte syndrome. A new disorder of neutrophil function. Lancet (1971) 1.98
Chemotactic factor inactivator in normal human serum. J Clin Invest (1973) 1.93
Defective chemotaxis associated with a serum inhibitor in cirrhotic patients. N Engl J Med (1972) 1.92
Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator. N Engl J Med (1974) 1.88
Separation and functional characterization of human neutrophil subpopulations. Blood (1978) 1.80
Impaired neutrophil chemotaxis in patients with juvenile and rapidly progressing periodontitis. J Periodontal Res (1979) 1.70
Defective polymorphonuclear leukocyte function in a human periodontal disease. Nature (1977) 1.59
Defective neutrophil chemotaxis and cellular immunity in a child with recurrent infections. Ann Intern Med (1973) 1.42
Defective leukotaxis in patients with lepromatous leprosy. J Lab Clin Med (1976) 1.41
Histopathologic features of the initial and early stages of experimental gingivitis in man. J Periodontal Res (1975) 1.37
Defective neutrophil chemotaxis in juvenile periodontitis. Infect Immun (1977) 1.36
Dental research in microbiology with emphasis on periodontal disease. J Am Dent Assoc (1969) 1.35
Defective regulation of chemotaxis in cirrhosis. J Lab Clin Med (1975) 1.32
Hyperactivity of neutrophil leukotactic responses during active bacterial infection. J Clin Invest (1974) 1.29
Defective neutrophil motility in children with measles. J Pediatr (1976) 1.17
Neutrophil granulocyte function in patients with pulmonary infection. J Pediatr (1974) 1.13
Correlated morphometric and biochemical analysis of gingival tissue in early chronic gingivitis in man. Arch Oral Biol (1973) 1.12
A serum inhibitor of leukotaxis in a child with recurrent infections. J Lab Clin Med (1972) 1.09
Transmigration and infiltration of leucocytes in human junctional epithelium. Helv Odontol Acta (1973) 1.08
Infection, dermatitis, increased IgE, and impaired neutrophil chemotaxis. A possible relationship. Arch Dermatol (1976) 1.06
Leukotactic activity and reduction of nitroblue tetrazolium by neutrophil granulocytes from patients with streptococcal skin infection. J Infect Dis (1974) 1.05
Immunologic reactions and periodontal inflammation. J Dent Res (1970) 1.01
Serum chemotactic inhibitory activity: heat activation of chemotactic inhibition. Infect Immun (1976) 1.00
Evaluation of tetracycline in the neutrophil chemotactic response. J Lab Clin Med (1977) 1.00
Impaired leukotactic responsiveness in patients with juvenile diabetes mellitus. Clin Immunol Immunopathol (1974) 0.99
Epidemiological studies of periodontal diseases. Am J Public Health Nations Health (1968) 0.98
Partial characterization of a cell-directed inhibitor of leukotaxis in human serum. J Lab Clin Med (1977) 0.95
Defective neutrophil motility in hypovitaminosis D rickets. Acta Paediatr Scand (1976) 0.93
Stereologic analysis of chronic lymphoid cell infiltrates in human gingiva. Arch Oral Biol (1976) 0.91
Defect of neutrophil motility in a child with recurrent bacterial infections and disseminated cytomegalovirus infection. J Pediatr (1973) 0.87
Neutrophil chemotactic activity elaborated by dental plaque. J Periodontal Res (1972) 0.85
Elevation of a serum component in periodontal disease capable of modulating chemotactic infiltration. J Periodontal Res (1975) 0.84
Host resistance and periodontal disease. J Dent Res (1970) 0.82
An inherited defect in granulocyte function: impaired chemotaxis, phagocytosis and intracellular killing of microorganisms. Helv Paediatr Acta (1976) 0.78
Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res (2012) 5.57
Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival, and tissue destruction. J Dent Res (1984) 5.29
Actinobacillus actinomycetemcomitans in human periodontal disease: a cross-sectional microbiological investigation. Infect Immun (1980) 4.87
Periodontal disease and risk of cerebrovascular disease: the first national health and nutrition examination survey and its follow-up study. Arch Intern Med (2000) 3.82
Identification of periodontal pathogens in atheromatous plaques. J Periodontol (2000) 3.45
Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol (1994) 3.20
Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontol (1998) 3.12
Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease. Infect Immun (1983) 3.04
Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol (2001) 2.97
Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun (2000) 2.95
Serum antibodies to oral Bacteroides asaccharolyticus (Bacteroides gingivalis): relationship to age and periondontal disease. Infect Immun (1981) 2.93
Examination of the relation between periodontal health status and cardiovascular risk factors: serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen. Am J Epidemiol (2000) 2.64
Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats. J Bacteriol (1994) 2.59
RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis. FASEB J (2005) 2.47
Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol (1997) 2.39
Inhibition of glucosyltransferase activity by antisera to known serotypes of Streptococcus mutans. Infect Immun (1973) 2.37
Does periodontal treatment improve glycemic control in diabetic patients? A meta-analysis of intervention studies. J Dent Res (2005) 2.27
Molecular cloning and sequencing of the gene encoding the fimbrial subunit protein of Bacteroides gingivalis. J Bacteriol (1988) 2.25
Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol (1991) 2.18
Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol (1995) 2.15
Heterogeneity of virulence among strains of Bacteroides gingivalis. J Periodontal Res (1989) 1.99
Human immune responses to oral micro-organisms. I. Association of localized juvenile periodontitis (LJP) with serum antibody responses to Actinobacillus actinomycetemcomitans. Clin Exp Immunol (1982) 1.93
Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol (1996) 1.90
Synthetic peptides analogous to the fimbrillin sequence inhibit adherence of Porphyromonas gingivalis. Infect Immun (1992) 1.90
Host responses in periodontal diseases. J Dent Res (1984) 1.90
Purification and properties of hemagglutinin from culture supernatant of Bacteroides gingivalis. Infect Immun (1986) 1.85
A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells. Infect Immun (1997) 1.84
Direct hemagglutination technique for differentiating Bacteroides asaccharolyticus oral strains from nonoral strains. J Clin Microbiol (1979) 1.84
Antigenic studies of oral and nonoral black-pigmented Bacteroides strains. Infect Immun (1980) 1.84
Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction. Infect Immun (1992) 1.82
Cloning, expression, and sequencing of a cell surface antigen containing a leucine-rich repeat motif from Bacteroides forsythus ATCC 43037. Infect Immun (1998) 1.79
Haim-Munk syndrome and Papillon-Lefèvre syndrome are allelic mutations in cathepsin C. J Med Genet (2000) 1.78
Secretory gamma-A antibodies induced by local immunization. Nature (1969) 1.76
Prevention of Streptococcus mutans infection of tooth surfaces by salivary antibody in Irus monkeys (Macaca fascicularis). Infect Immun (1975) 1.74
The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodontal Res (1986) 1.72
Self-reported measures for surveillance of periodontitis. J Dent Res (2013) 1.69
Porphyromonas (Bacteroides) gingivalis fimbrillin: size, amino-terminal sequence, and antigenic heterogeneity. Infect Immun (1991) 1.67
Clinical criteria for the definition of "established periodontitis". J Periodontol (1992) 1.65
The relationship between bone mineral density and periodontitis in postmenopausal women. J Periodontol (2000) 1.63
Tissue localization of Actinobacillus actinomycetemcomitans in human periodontitis. I. Light, immunofluorescence and electron microscopic studies. J Periodontol (1987) 1.63
Characterization of tufted streptococci isolated from the "corn cob" configuration of human dental plaque. Infect Immun (1980) 1.63
Defective polymorphonuclear leukocyte function in a human periodontal disease. Nature (1977) 1.59
Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc (1990) 1.59
Blastogenic response of human lymphocytes to oral bacterial antigens: comparison of individuals with periodontal disease to normal and edentulous subjects. Infect Immun (1976) 1.56
Purification, characterization and immunolocalization of fimbrial protein from Porphyromonas (bacteroides) gingivalis. Biochem Biophys Res Commun (1991) 1.54
Studies of leukotoxin from Actinobacillus actinomycetemcomitans using the promyelocytic HL-60 cell line. Infect Immun (1983) 1.53
Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-alpha and IL-1 beta production by human monocytes. J Immunol (1994) 1.53
Identification of Bacteroides gingivalis by fluorescent antibody staining. Ann Microbiol (Paris) (1982) 1.53
The role of osteopenia in oral bone loss and periodontal disease. J Periodontol (1996) 1.51
Actinobacillus actinomycetemcomitans in human periodontal disease. Association, serology, leukotoxicity, and treatment. J Periodontal Res (1982) 1.50
Osteoporosis and oral infection: independent risk factors for oral bone loss. J Dent Res (2008) 1.48
Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia (2010) 1.48
Serum neutralizing activity against Actinobacillus actinomycetemcomitans leukotoxin in juvenile periodontitis. J Clin Periodontol (1981) 1.45
Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmic nuclear factor kappaB. Infect Immun (1999) 1.43
Effects of temperature stress on expression of fimbriae and superoxide dismutase by Porphyromonas gingivalis. Infect Immun (1994) 1.42
Surface thermodynamics of normal and pathological human granulocytes. Cell Biophys (1980) 1.38
Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Biochemistry (2000) 1.38
Inhibition of neutrophil chemotaxis by soluble bacterial products. J Periodontol (1982) 1.38
Periodontal disease and NIDDM in Pima Indians. Diabetes Care (1990) 1.36
Longitudinal study of prognostic factors in established periodontitis patients. J Clin Periodontol (1997) 1.36
Salivary receptors for recombinant fimbrillin of Porphyromonas gingivalis. Infect Immun (1994) 1.36
The immunoglobulins of equine colostrum and parotid fluid. J Immunol (1969) 1.36
Actinobacillus actinomycetemcomitans in the pathogenesis of human periodontal disease. Adv Dent Res (1988) 1.36
Dietary vitamin C and the risk for periodontal disease. J Periodontol (2000) 1.36
Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial. J Periodontol (2001) 1.35
Dental research in microbiology with emphasis on periodontal disease. J Am Dent Assoc (1969) 1.35
Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes). J Am Dent Assoc (1982) 1.33
Antibody response in the parotid fluid and serum of Irus monkeys (Macaca fascicularis) after local immunization with Streptococcus mutans. Infect Immun (1975) 1.31
Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. J Leukoc Biol (2005) 1.31
Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing, and of adjunctive tetracycline therapy. J Periodontol (1979) 1.30
Evaluation of Fluoretec-M for detection of oral strains of Bacteroides asaccharolyticus and Bacteroides melaninogenicus. J Clin Microbiol (1980) 1.29
Prevalence of dental caries and treatment needs in the school-going children of rural areas in Udaipur district. J Indian Soc Pedod Prev Dent (2007) 1.29
Cigarette smoking increases the risk for subgingival infection with periodontal pathogens. J Periodontol (1996) 1.29
Isolation and characterization of a minor fimbria from Porphyromonas gingivalis. Infect Immun (1996) 1.29
Combined micromanipulation, culture and immunofluorescent techniques for isolation of the coccal organisms comprising the "corn cob" configuration of human dental plaque. J Biol Buccale (1977) 1.28
Prophyromonas gingivalis fimbriae mediate coaggregation with Streptococcus oralis through specific domains. J Dent Res (1997) 1.26
Gingival fluid and serum in periodontal diseases. I. Quantitative study of immunoglobulins, complement components, and other plasma proteins. J Periodontol (1977) 1.25
A biochemical approach to periodontal regeneration: tetracycline treatment of dentin promotes fibroblast adhesion and growth. J Periodontal Res (1986) 1.24
Periodontal disease and risk of coronary heart disease. JAMA (2001) 1.23
Genetic heterogeneity of Porphyromonas (Bacteroides) gingivalis by genomic DNA fingerprinting. J Dent Res (1990) 1.23
Longitudinal study of predictive factors for periodontal disease and tooth loss. J Clin Periodontol (1999) 1.22
Position paper: sonic and ultrasonic scalers in periodontics. Research, Science and Therapy Committee of the American Academy of Periodontology. J Periodontol (2000) 1.22
Mitogenic, chemotactic, and synthetic responses of rat periodontal ligament fibroblastic cells to polypeptide growth factors in vitro. J Periodontol (1992) 1.21
Prevalence of gingival diseases, malocclusion and fluorosis in school-going children of rural areas in Udaipur district. J Indian Soc Pedod Prev Dent (2007) 1.21
Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol (1998) 1.20
Rapid identification of periodontal pathogens in subgingival plaque: comparison of indirect immunofluorescence microscopy with bacterial culture for detection of Actinobacillus actinomycetemcomitans. J Dent Res (1985) 1.20
Porphyromonas gingivalis lipopolysaccharide stimulation of human monocytes: dependence on serum and CD14 receptor. Oral Microbiol Immunol (1994) 1.19
In vitro antimicrobial susceptibility of Actinobacillus actinomycetemcomitans. Antimicrob Agents Chemother (1980) 1.18
Structural domains of Porphyromonas gingivalis recombinant fimbrillin that mediate binding to salivary proline-rich protein and statherin. Infect Immun (1996) 1.18
Periodontopathic potential of two strains of Porphyromonas gingivalis in gnotobiotic rats. Arch Oral Biol (1992) 1.18
Neutrophil chemotaxis in families with localized juvenile periodontitis. J Periodontal Res (1985) 1.18
Oxidative and nonoxidative killing of Actinobacillus actinomycetemcomitans by human neutrophils. Infect Immun (1986) 1.17
Specificity of antibodies to Streptococcus mutans; significance in inhibition of adherence. Adv Exp Med Biol (1974) 1.17
A biochemical approach to periodontal regeneration: tetracycline treatment conditions dentin surfaces. J Periodontal Res (1986) 1.16
The Papillon-Lefèvre syndrome: neutrophil dysfunction with severe periodontal disease. Clin Immunol Immunopathol (1984) 1.16